Page 779 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 779

750          Part SIX  Systemic Immune Diseases


        blood away from the skin surface during cold exposure and   Digital sympathectomy is used when medical therapy has failed
        increases surface blood flow during hot ambient temperatures.   to reverse critical digital ischemia. In a few cases, macrovascular
        Arteriovenous  anastomoses  (AVAs)  connecting  arterioles  and   occlusive disease (particularly in the ulnar artery) can be surgically
        venules allow blood to bypass capillaries, thus allowing rapid and   bypassed to improve distal blood flow.
        marked increases in cutaneous blood flow. Increased activity of
        the sympathetic nervous system via both the CNS (body chilling)   Gastrointestinal Involvement
        and the peripheral nervous system (local cooling of skin) initiates   GI disease is a major cause of morbidity and mortality and
        vasoconstriction and heat conservation. Selective responses to   accounts  for  one  of  the  most  frequent  initial  symptoms  of
        cold by AVAs allow preservation of nutritional blood flow through   scleroderma. Every part of the GI tract can be involved, including
        skin capillaries. Raynaud phenomenon–associated increase in   the oral pharynx, esophagus, stomach, and the small and large
        vascular tone results, in part, from a defect in the vascular response   bowels.  A reduced oral aperture (microstomia) is not only
        to normal sympathetic signals. Studies find that α 2  adrenergic   cosmetically unpleasant, but it also impairs daily hygiene and
        receptors on the smooth muscle cells of cutaneous vessels mediate   normal mastication. Periodontal disease is a consequence of
        vasoconstriction in AVAs during a response to cold temperature.   several factors, including decrease salvia, difficulty in dental care,
        This response to sympathetic input is abnormally increased in   GI efflux disease, gum recession, and bone resorption. Caries
        patients with Raynaud phenomenon. 15                   and tooth loss can result. Initial symptoms are difficulty chewing
           Raynaud phenomenon is clinically defined as well-demarcated   and difficulty swallowing dry or a larger bolus of food.
        color changes of the digits induced by cold or emotional stress.   Almost all patients with SSc demonstrate evidence of distal
        Vascular constriction of AVSs, arterioles, and small arteries in   esophageal dysfunction. Clinically, this presents with dysphagia,
        the skin and tissues of the digits causes the pallor of the digits,   heartburn, and regurgitation typical of gastroesophageal reflux
        the phase of complete loss of blood flow. The initial vasospasm   disease (GERD). These symptoms are caused by peristaltic dysfunc-
        and pallor is followed by cyanosis of the skin caused by venous   tion of the distal esophagus, decreased lower esophageal sphincter
        pooling and low flow with deoxygenated blood. Finally, after   (LES) pressure, and delayed gastric emptying, which is thought
        rewarming, the recovery phase occurs with vasodilation manifested   to be secondary to autonomic dysfunction. Pathological studies
        by hyperemia with blushed reddened skin as blood flow rebounds.   of the esophagus show that the smooth muscle (circular greater
        Raynaud phenomenon affects as much as 3–5% of the general   than longitudinal) of the bowel atrophies without significant
                                                                                                       18
        population. Raynaud phenomenon is considered to be primary   fibrosis, vascular injury, or obvious inflammation.  Functional
        when there is no other associated disease state. In these cases, it   and pharmacological studies have shown that a neurogenic
        is thought to represent a genetic trait with cold sensitivity as a   process precedes smooth muscle dysfunction. Autoantibodies
        result of abnormal cutaneous vessel reactivity to environmental   directed against enteric neurons and antimuscarinic antibodies
        temperatures. In SSc, the disease process targets the peripheral   are found, suggesting  that an  immune process  is involved in
        vasculature, including AVAs or thermoregulatory blood vessels.   the pathogenesis of bowel dysmotility. Esophageal manometric
        This leads to not only the abnormal reactivity to ambient   evaluation reveals the characteristic triad of low or absent primary
        temperatures typical of Raynaud phenomenon but also significant   and secondary peristaltic activity in the distal esophagus, normal
        structural disease of blood vessels, which causes tissue ischemia   proximal esophageal (striated muscle) motility, and the loss of the
        as a result of compromise to blood flow within capillaries or   LES tone. Complications include reflux esophagitis, esophageal
        nutritional vessels. As a consequence of both an exaggerated   strictures, mucosal erosions, and bleeding; Barrett metaplasia
        response to cold and structural vascular disease, patients with   or, very rarely, adenocarcinoma may also develop.
        SSc have severe Raynaud phenomenon with multiple, and often   Early satiety, bloating, nausea, periodic vomiting, and decreased
        prolonged, daily episodes. The severe vascular disease can lead   appetite with weight loss are seen secondary to poor gastric
        to critical ischemia with digital ulcerations or deep tissue infarc-  emptying and retention of food and liquids in the stomach.
        tion and gangrene. The vascular disease in SSc is not limited to   Gastroparesis is commonly associated with esophageal dysfunction
        skin but is systemic. There is evidence that abnormal vascular   and aggravates GERD. Dilatation of mucosal capillaries in the
        reactivity resulting in tissue injury occurs in the pulmonary,   GI tract is common, particularly in the gastric antrum. Gastric
        renal, GI, and coronary circulations.                  antral vascular ectasia (GAVE), also known as  “watermelon
           Treatment of Raynaud phenomenon must be individualized   stomach,” is the major gastric manifestation, which may lead to
        and adjusted according to its severity. Initial therapy should   occult bleeding and significant anemia. Intestinal dysmotility
        include avoidance of cold exposure and use of methods of stress   can involve the small and large bowels. Patients may note a
        reduction.  The  best  studied  medications  to  treat  Raynaud   change in bowel habits or present with episodes of pseudoobstruc-
        phenomenon are the calcium channel blockers (e.g., nifedipine),   tion with severe abdominal pain, bloating, abdominal distension,
        which remain the recommended first choice of therapy. Other   and vomiting. Persistent diarrhea may be a manifestation of
        vasoactive drugs reported to be helpful include the phosphodi-  malabsorption of fats as a result of bacterial overgrowth in the
        esterase inhibitors, such as sildenafil; serotonin reuptake inhibitors,   atonic small bowel and can be associated with dramatic weight
        such as fluoxetine; nitrates, such as topical nitroglycerine; and   loss and malnutrition. In the late stages, the bowel wall thins
                              16
        intravenous prostaglandins.  Bosentan, an endothelin-1 receptor   out and traps air (pneumatosis cystoides intestinalis). Wide-mouth
        inhibitor, was recently shown to reduce the incidence of new   diverticuli develop in the colon or the bowel and may rupture.
        digital ulcers in patients with SSc but not to alter the frequency   Incontinence of stool can occur as a result of dysfunction of
                        17
        of Raynaud events.  Statins may also protect peripheral blood   anal sphincters.
        vessels and prevent ischemic digital ulcers, and antioxidants have
        the potential to reduce oxidative stress to tissues. Botulinum   Pulmonary Involvement
        toxin injected locally at the base of the fingers is reported to be   Lung  disease  is  now  the  leading  cause  of  death  in  patients
        helpful, but a controlled clinical trial is needed to define its role.   with SSc and accounts for significant lifetime morbidity. Lung
   774   775   776   777   778   779   780   781   782   783   784